Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia: A case report

Heart, Artery and Coronary DiseasesLipid-Lowering Drugs
Do you want to read an article? Please log in or register.